Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds

A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.

from NYT > Health https://ift.tt/Wh7mPTU
via health&fitness